Hartford Funding Administration Co. lowered its stake in shares of Enphase Vitality, Inc. (NASDAQ:ENPH – Get Ranking) by 7.1% within the 1st quarter, HoldingsChannel experiences. The agency owned 12,808 shares of the semiconductor firm’s inventory after promoting 982 shares throughout the quarter. Hartford Funding Administration Co.’s holdings in Enphase Vitality had been value $2,584,000 as of its most up-to-date submitting with the Securities & Trade Fee.

Quite a few different institutional buyers and hedge funds have additionally added to or decreased their stakes within the inventory. Congress Asset Administration Co. MA purchased a brand new place in Enphase Vitality within the 1st quarter value roughly $4,352,000. Xponance Inc. boosted its holdings in Enphase Vitality by 1.1% within the 1st quarter. Xponance Inc. now owns 22,172 shares of the semiconductor firm’s inventory value $4,474,000 after shopping for a further 252 shares throughout the interval. Nice Valley Advisor Group Inc. boosted its holdings in Enphase Vitality by 38.5% within the 1st quarter. Nice Valley Advisor Group Inc. now owns 13,423 shares of the semiconductor firm’s inventory value $2,707,000 after shopping for a further 3,730 shares throughout the interval. Wedbush Securities Inc. purchased a brand new place in Enphase Vitality within the 1st quarter value roughly $272,000. Lastly, Ellevest Inc. boosted its holdings in Enphase Vitality by 73.1% within the 1st quarter. Ellevest Inc. now owns 206 shares of the semiconductor firm’s inventory value $42,000 after shopping for a further 87 shares throughout the interval. 68.30% of the inventory is owned by institutional buyers.

A number of analysis analysts just lately commented on the inventory. StockNews.com assumed protection on shares of Enphase Vitality in a report on Thursday, March 31st. They issued a “maintain” score for the corporate. Cowen raised their value goal on shares of Enphase Vitality from $227.00 to $240.00 in a report on Wednesday, April 27th. Credit score Suisse Group raised their value goal on shares of Enphase Vitality from $163.00 to $174.00 in a report on Thursday, April 28th. KeyCorp raised their value goal on shares of Enphase Vitality from $200.00 to $220.00 and gave the corporate an “chubby” score in a report on Thursday, April seventh. Lastly, BMO Capital Markets raised their value goal on shares of Enphase Vitality from $215.00 to $240.00 in a report on Friday, June 10th. 5 analysts have rated the inventory with a maintain score and twenty have given a purchase score to the corporate. Based on MarketBeat.com, the corporate at present has a median score of “Reasonable Purchase” and a consensus value goal of $238.41.

ENPH inventory opened at $195.72 on Friday. The agency’s 50-day shifting common value is $178.12 and its two-hundred day shifting common value is $170.78. Enphase Vitality, Inc. has a 12-month low of $113.40 and a 12-month excessive of $282.46. The inventory has a market capitalization of $26.43 billion, a price-to-earnings ratio of 167.28, a PEG ratio of two.02 and a beta of 1.37. The corporate has a present ratio of three.44, a fast ratio of three.22 and a debt-to-equity ratio of three.62.

Enphase Vitality (NASDAQ:ENPH – Get Ranking) final launched its quarterly earnings knowledge on Tuesday, April 26th. The semiconductor firm reported $0.44 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.43 by $0.01. Enphase Vitality had a web margin of 10.88% and a return on fairness of 45.30%. The agency had income of $441.29 million for the quarter, in comparison with analysts’ expectations of $434.21 million. Throughout the identical quarter within the earlier yr, the corporate earned $0.48 earnings per share. Equities analysts predict that Enphase Vitality, Inc. will submit 2.35 EPS for the present yr.

In different Enphase Vitality information, Director Benjamin John Kortlang offered 25,000 shares of the enterprise’s inventory in a transaction dated Thursday, June 2nd. The shares had been offered at a median value of $197.89, for a complete worth of $4,947,250.00. Following the transaction, the director now owns 249,289 shares within the firm, valued at $49,331,800.21. The transaction was disclosed in a submitting with the Securities & Trade Fee, which is obtainable by way of this hyperlink. Additionally, Director Joseph Ian Malchow offered 12,500 shares of the enterprise’s inventory in a transaction dated Wednesday, June 15th. The shares had been offered at a median value of $188.00, for a complete transaction of $2,350,000.00. Following the completion of the transaction, the director now owns 67,590 shares within the firm, valued at roughly $12,706,920. The disclosure for this sale may be discovered right here. Insiders offered 153,850 shares of firm inventory value $30,289,084 within the final 90 days. Company insiders personal 4.80% of the corporate’s inventory.

Enphase Vitality Firm Profile (Get Ranking)

Enphase Vitality, Inc, along with its subsidiaries, designs, develops, manufactures, and sells house vitality options for the photo voltaic photovoltaic trade in the USA and internationally. The corporate gives semiconductor-based microinverter, which converts vitality on the particular person photo voltaic module stage, and combines with its proprietary networking and software program applied sciences to offer vitality monitoring and management providers.

See Additionally

Need to see what different hedge funds are holding ENPH? Go to HoldingsChannel.com to get the newest 13F filings and insider trades for Enphase Vitality, Inc. (NASDAQ:ENPH – Get Ranking).

Obtain Information & Scores for Enphase Vitality Each day – Enter your e mail handle beneath to obtain a concise every day abstract of the newest information and analysts’ scores for Enphase Vitality and associated corporations with MarketBeat.com’s FREE every day e mail publication.